Increased monocyte chemoattractant protein-1 levels indicating early vascular damage in lean young PCOS patients

被引：27

作者：

Atabekoglu, Cem Somer ^{[1
,2
]}

Sonmezer, Murat ^{[1
,2
]}

Ozmen, Batuhan ^{[1
,2
]}

Yarci, Asli ^{[1
]}

Akbiyik, Filiz ^{[3
]}

Tasci, Tolga ^{[1
]}

Aytac, Rusen ^{[1
,2
]}

机构：

[1] Ankara Univ, Dept Obstet & Gynecol, Sch Med, TR-06100 Ankara, Turkey

[2] Ankara Univ, Ctr Res Human Reprod, Sch Med, TR-06100 Ankara, Turkey

[3] Hacettepe Univ, Sch Med, Dept Biochem, Ankara, Turkey

来源：

FERTILITY AND STERILITY | 2011年 / 95卷 / 01期

关键词：

Polycystic Ovary Syndrome; MCP-1; Early Vascular Damage; POLYCYSTIC-OVARY-SYNDROME; CHEMOTACTIC PROTEIN-1; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; OBESE WOMEN; CYTOKINES; INFLAMMATION; ATHEROSCLEROSIS; EXPRESSION; HEALTH;

D O I：

10.1016/j.fertnstert.2010.08.030

中图分类号：

R71 [妇产科学];

学科分类号：

100211 [妇产科学];

摘要：

Serum levels of monocyte chemoattractant protein-1 and C-reactive protein levels, as early signs of vascular damage and cardiovascular disease, were increased in young, lean patients with polycystic ovary syndrome. Serum monocyte chemoattractant protein-1 levels were positively correlated with serum LH, T, and C-reactive protein levels. (Fertil Steril (R) 2011;95:295-7. (C) 2011 by American Society for Reproductive Medicine.)

引用

收藏

页码：295 / 297

页数：3

相关论文

共 32 条

[1]

Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice [J].

Aiello, RJ ;

Bourassa, PAK ;

Lindsey, S ;

Weng, WF ;

Natoli, E ;

Rollins, BJ ;

Milos, PM .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (06) :1518-1525

[2]

Monocyte chemotactic protein-1 expression in human preovulatory follicles and ovarian cells [J].

Arici, A ;

Oral, E ;

Bukulmez, O ;

Buradagunta, S ;

Bahtiyar, O ;

Jones, EE .

JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1997, 32 (03) :201-219

[3]

Cytokines and steroidogenesis [J].

Bornstein, SR ;

Rutkowski, H ;

Vrezas, I .

MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 215 (1-2) :135-141

[4]

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].

Chang, J ;

Azziz, R ;

Legro, R ;

Dewailly, D ;

Franks, S ;

Tarlatzis, BC ;

Fauser, B ;

Balen, A ;

Bouchard, P ;

Dahlgren, E ;

Devoto, L ;

Diamanti, E ;

Dunaif, A ;

Filicori, M ;

Homburg, R ;

Ibanez, L ;

Laven, J ;

Magoffin, D ;

Nestler, J ;

Norman, RJ ;

Pasquali, R ;

Pugeat, M ;

Strauss, J ;

Tan, S ;

Taylor, A ;

Wild, R ;

Wild, S ;

Ehrmann, D ;

Lobo, R .

FERTILITY AND STERILITY, 2004, 81 (01) :19-25

[5]

Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives [J].

Cussons, AJ ;

Stuckey, BGA ;

Watts, GF .

ATHEROSCLEROSIS, 2006, 185 (02) :227-239

[6]

Monocyte chemotactic protein-1 in the follicle of the menstrual and IVF cycle [J].

Dahm-Kähler, P ;

Runesson, E ;

Lind, AK ;

Brännström, M .

MOLECULAR HUMAN REPRODUCTION, 2006, 12 (01) :1-6

[7]

Cardiovascular disease risk factors in polycystic ovary syndrome [J].

Dokras, Anuia .

SEMINARS IN REPRODUCTIVE MEDICINE, 2008, 26 (01) :39-44

[8]

Obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome [J].

Dokras, Anuja ;

Jagasia, Dinesh H. ;

Maifeld, Michelle ;

Sinkey, Christine A. ;

VanVoorhis, Bradley J. ;

Haynes, William G. .

FERTILITY AND STERILITY, 2006, 86 (06) :1702-1709

[9]

Hormones and cardiovascular health in women [J].

Farley, T. ;

Fauser, B. ;

Glasier, A. ;

Greer, I. ;

Hanson, M. A. ;

La Vecchia, C. ;

Mishell, D. ;

Rosano, G. ;

Simon, T. ;

Baird, D. T. ;

Benagiano, G. ;

Collins, J. ;

Crosignani, P. G. ;

Diczfalusy, E. ;

Lanzone, A. ;

Negri, E. ;

Schmidt-Gollwitzer, K. ;

Skouby, S. O. ;

Volpe, A. .

HUMAN REPRODUCTION UPDATE, 2006, 12 (05) :483-497

[10]

FARUQI RM, 1993, BRIT HEART J, V69, pS19

← 1 2 3 4 →